122 related articles for article (PubMed ID: 1536795)
41. Detection of minimal residual disease in Philadelphia chromosome positive acute lymphoblastic leukemia: rationale for bone marrow transplantation from the polymerase chain reaction point of view.
Miyamura K; Takeo T; Kataoka T; Tahara T; Tanimoto M; Saito H
Leuk Lymphoma; 1993 Oct; 11(3-4):181-9. PubMed ID: 8260893
[TBL] [Abstract][Full Text] [Related]
42. [Pilot treatment for 13 BCR-ABL positive leukemia patients with T315I mutation].
Zhou M; Sha X; Qiu H; Cen J; Shen H; Sun A; Wu D
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):162-4. PubMed ID: 24606661
[No Abstract] [Full Text] [Related]
43. Treatment of relapsed blast-phase Philadelphia-chromosome-positive leukaemia after non-myeloablative stem-cell transplantation with donor lymphocytes and imatinib.
Savani BN; Srinivasan R; Espinoza-Delgado I; Dorrance C; Takahashi Y; Igarashi T; Rezvani K; Lundqvist A; Barrett AJ; Childs RW
Lancet Oncol; 2005 Oct; 6(10):809-12. PubMed ID: 16198987
[No Abstract] [Full Text] [Related]
44. Molecular genetics of chronic myelogenous leukemia.
Hooberman AL
Ann Intern Med; 1990 Dec; 113(11):898-9. PubMed ID: 2240908
[No Abstract] [Full Text] [Related]
45. Molecular methods to detect the Philadelphia chromosome.
Hooberman AL; Westbrook CA
Clin Lab Med; 1990 Dec; 10(4):839-55. PubMed ID: 2272177
[TBL] [Abstract][Full Text] [Related]
46. Adult leukaemia in 1995: new directions.
Scheinberg DA
Lancet; 1995 Aug; 346(8973):455-6. PubMed ID: 7637474
[No Abstract] [Full Text] [Related]
47. [Analysis of breakpoints on BCR gene in acute leukemia patients with Ph1 chromosome].
Tanaka K; Takechi M; Shigeta C; Oguma N; Kamada N; Takimoto Y; Kuramoto A; Kyo T; Dohi H; Nakamura Y
Rinsho Ketsueki; 1992 Jan; 33(1):1-10. PubMed ID: 1545509
[TBL] [Abstract][Full Text] [Related]
48. A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase.
Saito Y; Uzuka Y; Sakai N; Suzuki S; Toyota T
Bone Marrow Transplant; 2000 Jun; 25(11):1209-11. PubMed ID: 10849535
[TBL] [Abstract][Full Text] [Related]
49. Myeloperoxidase mRNA analysis in acute lymphoblastic leukemia.
Serrano J; Román J; Sánchez J; Torres A
Diagn Mol Pathol; 1997 Jun; 6(3):175-6. PubMed ID: 9276191
[No Abstract] [Full Text] [Related]
50. Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study.
Jabbour E; Kantarjian H; Ravandi F; Thomas D; Huang X; Faderl S; Pemmaraju N; Daver N; Garcia-Manero G; Sasaki K; Cortes J; Garris R; Yin CC; Khoury JD; Jorgensen J; Estrov Z; Bohannan Z; Konopleva M; Kadia T; Jain N; DiNardo C; Wierda W; Jeanis V; O'Brien S
Lancet Oncol; 2015 Nov; 16(15):1547-1555. PubMed ID: 26432046
[TBL] [Abstract][Full Text] [Related]
51. Ponatinib in the treatment of chronic myeloid leukemia and philadelphia chromosome positive acute lymphoblastic leukemia.
Pavlovsky C; Chan O; Talati C; Pinilla-Ibarz J
Future Oncol; 2019 Jan; 15(3):257-269. PubMed ID: 30251548
[TBL] [Abstract][Full Text] [Related]
52. Polymerase chain reaction analysis of BCR-ABL sequences in adult Philadelphia chromosome-negative acute lymphoblastic leukemia patients.
Janssen JW; Fonatsch C; Ludwig WD; Rieder H; Maurer J; Bartram CR
Leukemia; 1992 May; 6(5):463-4. PubMed ID: 1593911
[TBL] [Abstract][Full Text] [Related]
53. Miniaturized flow cytometry-based BCR-ABL immunoassay in detecting leptomeningeal disease.
D'Alessio F; Mirabelli P; Mariotti E; Raia M; Di Noto R; Fortunato G; Camera A; Del Vecchio L
Leuk Res; 2011 Oct; 35(10):1290-3. PubMed ID: 21658767
[TBL] [Abstract][Full Text] [Related]
54. A nested RT-PCR assay to detect BCR/abl.
Wasserman LM
Methods Mol Med; 2004; 97():181-9. PubMed ID: 15064493
[No Abstract] [Full Text] [Related]
55. Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Hooberman AL; Carrino JJ; Leibowitz D; Rowley JD; Le Beau MM; Arlin ZA; Westbrook CA
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4259-63. PubMed ID: 2498881
[TBL] [Abstract][Full Text] [Related]
56. Molecular methods in diagnosis and monitoring of haematological malignancies.
Yeung DT; Parker WT; Branford S
Pathology; 2011 Oct; 43(6):566-79. PubMed ID: 21881536
[TBL] [Abstract][Full Text] [Related]
57. Minor BCR (m-bcr) rearrangements may appear in major BCR (M-bcr)-positive CML cases.
Karlic H; Grill R; Schlögl E
Hematol Pathol; 1992; 6(4):203-7. PubMed ID: 1362728
[TBL] [Abstract][Full Text] [Related]
58. Do rosette, heterochromatin, and/or genomic imprinting influence preferential translocations in human neoplasia?
Verma RS
Cancer Genet Cytogenet; 2000 Jan; 116(2):174-5. PubMed ID: 10640153
[No Abstract] [Full Text] [Related]
59. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.
Ko BS; Tang JL; Lee FY; Liu MC; Tsai W; Chen YC; Wang CH; Sheng MC; Lin DT; Lin KH; Tien HF
Am J Hematol; 2002 Dec; 71(4):291-9. PubMed ID: 12447959
[TBL] [Abstract][Full Text] [Related]
60. [Clinical and molecular biological study of Ph positive acute leukemia: comparison with blast crisis of chronic myelogenous leukemia and Ph negative acute lymphoblastic leukemia].
Okada S; Shimizu T; Harada H; Miyoshi Y; Mori H; Niikura H; Omine M; Fujita K; Terada H
Rinsho Ketsueki; 1992 May; 33(5):646-54. PubMed ID: 1630016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
